Back in early August, I wrote about Maurie Hill, a Stargardt’s disease patient who is undergoing stem cell treatment as part of the Advanced Cell Technology clinical trial in which an injection of retinal pigment epithelial (RPE) cells derived from human embryonic stem cells, was injected into her retina in an attempt to stop the progression of her disease and, hopefully, restore some vision that she has lost.
That first posting, A Stargardt’s Clinical Trial Patient’s Story – In Her Own Words, told Maurie’s story, taken from the blog she is writing about her experiences in this clinical trial.